ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

ClinicalTrials.gov ID: NCT07225504

Public ClinicalTrials.gov record NCT07225504. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis

Study identification

NCT ID
NCT07225504
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,275 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Remibrutinib (Open label) Drug
  • Remibrutinib (blinded) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2025
Primary completion
Dec 2, 2030
Completion
Jan 1, 2034
Last update posted
Apr 23, 2026

2025 – 2034

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Alabama Neurology Associates PC Birmingham Alabama 35209 Recruiting
AZ Integrated Neuro and Spine Phoenix Arizona 85037 Recruiting
Center for Neurosciences Tucson Arizona 85718 Recruiting
Fullerton Neuro and Headache Ctr Fullerton California 92835 Recruiting
Regina Berkovich MD PhD Inc West Hollywood California 90048 Recruiting
Georgetown University Hospital Washington D.C. District of Columbia 20007 Recruiting
Neurology of Central FL Res Ctr Altamonte Springs Florida 32714 Recruiting
UF Health Cancer Center Gainesville Florida 32610 Recruiting
Neurology Associates PA Maitland Florida 32751 Recruiting
Aqualane Clinical Research Naples Florida 34105 Recruiting
Orlando Health Clinical Trials Orlando Florida 32806 Recruiting
Comprehensive Neurology Clinic Orlando Florida 32825 Recruiting
Neurology Associates of Ormond Beach Ormond Beach Florida 32174 Recruiting
Axiom Brain Health Tampa Florida 33609 Recruiting
Joi Life Wellness Group LLC Smyrna Georgia 30080 Recruiting
Hawaii Pacific Neuroscience LLC Honolulu Hawaii 96817 Recruiting
University of Kansas Hospital Kansas City Kansas 66160 Recruiting
Mid Atlantic Epilepsy and Sleep Ctr Bethesda Maryland 20817-1807 Recruiting
Michigan Institute of Neurological Farmington Hills Michigan 48334 Recruiting
Neurology Clinic PC Cordova Tennessee 38018 Recruiting
Saturn Research Solution Plano Texas 75024 Recruiting
Citta Clinical Research Spokane Washington 99202 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07225504, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07225504 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →